Source-grounded facts extracted from DIVERSIFIED HEALTHCARE TRUST's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
DIVERSIFIED HEALTHCARE TRUST shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent auditors at the 2026-06-10 meeting.
“The Company’s shareholders also ratified the appointment of Deloitte & Touche LLP as the Company’s independent auditors to serve for the 2026 fiscal year. This proposal received the following votes: For Against Abstain Broker Non-Votes 202,537,283 221,495 103,717 N/A”
DIVERSIFIED HEALTHCARE TRUST shareholders approved Advisory vote on executive compensation (Say-on-Pay) at the 2026-06-10 meeting.
“The Company’s shareholders also voted on a non-binding advisory resolution on the compensation paid to the Company’s named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the 2026 Proxy Statement. This proposal received the following votes: For Against Abstain Broker Non-Votes 176,612,032 8,812,215 245,865 17,192,383”
DIVERSIFIED HEALTHCARE TRUST shareholders approved Election of seven Trustees to the Board of Trustees for one-year terms at the 2026-06-10 meeting.
“The following persons were elected as Trustees and received the following votes: Nominee Votes For Withhold Broker Non-Votes Christopher J. Bilotto 181,906,682 3,763,430 17,192,383 Alan Felder 182,044,604 3,625,508 17,192,383 Lisa Harris Jones 160,305,823 25,364,289 17,192,383 Phyllis M. Hollis 181,544,266 4,125,846 17,192,383 Dawn K. Neher 176,872,256 8,797,856 17,192,383 Adam Portnoy 144,455,435 41,214,677 17,192,383 Jeffrey P. Somers 146,947,873 38,722,239 17,192,383”
DIVERSIFIED HEALTHCARE TRUST reported financial results for the quarter ended March 31, 2026.
“On May 4, 2026 , Diversified Healthcare Trust, or the Company, issued a summary press release and a detailed earnings presentation announcing the Company's financial results for the quarter ended March 31, 2026.”
Alan L. Felder was elected as Independent Trustee at DIVERSIFIED HEALTHCARE TRUST.
“On March 20, 2025, pursuant to the recommendation of the Nominating and Governance Committee, our Board of Trustees, or the Board, elected Alan L. Felder as an Independent Trustee with a term to expire at our 2025 annual meeting of shareholders.”
DIVERSIFIED HEALTHCARE TRUST completed a disposition for $159.0 million (closed 2025-01-31).
“On January 31, 2025, DHC completed the sale of three life science properties with approximately 186,000 rentable square feet located at 3030, 3040 and 3050 Science Park Road, San Diego, California, or MUSE, for a net sales price of $159.0 million, excluding closing costs.”
DIVERSIFIED HEALTHCARE TRUST reported financial results for the quarter ended March 31, 2024.
“Diversified Healthcare Trust Announces First Quarter 2024 Results”
DIVERSIFIED HEALTHCARE TRUST reported financial results for the quarter ended December 31, 2023.
“On February 26, 2024, Diversified Healthcare Trust, or the Company, issued a summary press release and a detailed earnings presentation announcing the Company's financial results for the quarter ended December 31, 2023.”
DIVERSIFIED HEALTHCARE TRUST incurred senior notes of $940,534,000 with U.S. Bank Trust Company, National Association at 11.25% per annum compounded semiannually maturing January 15, 2026.
“completed a private offering of $940,534,000 in aggregate principal amount at maturity of senior secured notes due 2026”
Christopher J. Bilotto was appointed as President and Chief Executive Officer at DIVERSIFIED HEALTHCARE TRUST.
“On November 17, 2023, our Board of Trustees, or the Board, appointed Christopher J. Bilotto as our President and Chief Executive Officer, effective January 1, 2024.”
Jennifer F. Francis resigned as President and Chief Executive Officer at DIVERSIFIED HEALTHCARE TRUST.
“Jennifer F. Francis, who is retiring from RMR on June 30, 2024, and therefore has resigned as our President and Chief Executive Officer, effective December 31, 2023.”
DIVERSIFIED HEALTHCARE TRUST reported financial results for the quarter ended September 30, 2023.
“Diversified Healthcare Trust Announces Third Quarter 2023 Results”
Richard W. Siedel, Jr. resigned as Chief Financial Officer and Treasurer at DIVERSIFIED HEALTHCARE TRUST.
“Mr. Brown will replace Richard W. Siedel, Jr., who has resigned as our Chief Financial Officer and Treasurer, effective September 30, 2023.”
Matthew C. Brown was appointed as Chief Financial Officer and Treasurer at DIVERSIFIED HEALTHCARE TRUST.
“Also on September 26, 2023, the Board appointed Matthew C. Brown as our Chief Financial Officer and Treasurer, effective October 1, 2023.”
Phyllis M. Hollis was elected as Independent Trustee at DIVERSIFIED HEALTHCARE TRUST.
“On September 26, 2023, pursuant to the recommendation of the Nominating and Governance Committee of the Board, the Board elected Phyllis M. Hollis as an Independent Trustee to fill one of the vacancies created by Messrs. LePage’s and Pierce’s resignations, and also decreased the size of the Board from seven to six Trustees.”
David A. Pierce resigned as Independent Trustee at DIVERSIFIED HEALTHCARE TRUST.
“On September 25, 2023, Daniel F. LePage and David A. Pierce each resigned as an Independent Trustee of our Board of Trustees, or the Board, effective that day.”
Daniel F. LePage resigned as Independent Trustee at DIVERSIFIED HEALTHCARE TRUST.
“On September 25, 2023, Daniel F. LePage and David A. Pierce each resigned as an Independent Trustee of our Board of Trustees, or the Board, effective that day.”
DIVERSIFIED HEALTHCARE TRUST terminated Agreement and Plan of Merger with Office Properties Income Trust valued at Mutual termination of Merger Agreement; no termination fee (effective 2023-09-01).
“On September 1, 2023, we and OPI mutually agreed to terminate the Merger Agreement and entered into a termination agreement, or the Termination Agreement.”
DIVERSIFIED HEALTHCARE TRUST reported financial results for the quarter and six months ended June 30, 2023.
“On August 1, 2023, Diversified Healthcare Trust, or the Company, issued a summary press release and a detailed earnings presentation announcing the Company's financial results for the quarter and six months ended June 30, 2023.”
DIVERSIFIED HEALTHCARE TRUST: Adopted Second Amended and Restated Bylaws to address the Universal Proxy Rules (Rule 14a-19) and certain technical updates (effective 2023-06-05).
“On June 5, 2023 the Board of Trustees (the “Board”) of the Company approved and adopted the Company’s Second Amended and Restated Bylaws (the “Amended Bylaws”). The Amended Bylaws address Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the “Universal Proxy Rules”) and certain technical updates.”
DIVERSIFIED HEALTHCARE TRUST shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent auditors for the 2023 fiscal year at the 2023-06-05 meeting.
“This proposal received the following votes: For Against Abstain Broker Non-Votes 186,446,590 19,557,321 463,990”
DIVERSIFIED HEALTHCARE TRUST shareholders approved Non-binding advisory vote on the frequency of future shareholder advisory votes to approve executive compensation at the 2023-06-05 meeting.
“This proposal received the following votes: One Year Two Years Three Years Abstain Broker Non-Votes 150,031,299 301,841 2,257,714 9,289,371 44,587,676”
DIVERSIFIED HEALTHCARE TRUST shareholders approved Non-binding advisory resolution on the compensation paid to the Company's named executive officers at the 2023-06-05 meeting.
“This proposal received the following votes: For Against Abstain Broker Non-Votes 134,727,264 26,778,560 374,401 44,587,676”
DIVERSIFIED HEALTHCARE TRUST shareholders approved Election of seven Trustees to the Board each for a one year term at the 2023-06-05 meeting.
“The following persons were elected as Trustees and received the following votes: Nominee Votes For Withhold Broker Non-Votes Jennifer F. Francis 138,781,131 23,099,094 44,587,676”
DIVERSIFIED HEALTHCARE TRUST reported financial results for the quarter ended March 31, 2023.
“On May 8, 2023, Diversified Healthcare Trust, or the Company, issued a summary press release and a detailed earnings presentation announcing the Company's financial results for the quarter ended March 31, 2023.”
DIVERSIFIED HEALTHCARE TRUST entered into Agreement and Plan of Merger with Office Properties Income Trust (effective 2023-04-11).
“On April 11, 2023, we and Office Properties Income Trust, or OPI, entered into an Agreement and Plan of Merger, or the Merger Agreement, pursuant to which, on the terms and subject to the satisfaction or waiver of the conditions thereof, we will be merged with and into OPI, with OPI continuing as the surviving entity in the merger, or the Merger.”
DIVERSIFIED HEALTHCARE TRUST reported the quarter ended December 31, 2022 results: net income Net loss attributable to common shareholders of $65.3 million, or $0.27 per share, EPS $0.27 per share.
“On March 1, 2023, Diversified Healthcare Trust, or the Company, issued a press release regarding the Company’s results of operations and financial condition for the quarter and year ended December 31, 2022, and also provided certain supplemental operating and financial data for the quarter and year ended December 31, 2022.”
DIVERSIFIED HEALTHCARE TRUST amended credit agreement with Wells Fargo Bank, National Association valued at Facility commitments reduced from $586.4 million to $450.0 million; minimum liquidity decreased from (effective 2023-02-14).
“On February 14, 2023, we amended the agreement governing our credit facility, or our credit agreement, with Wells Fargo Bank, National Association, as administrative agent and a lender, and a syndicate of other lenders.”
DIVERSIFIED HEALTHCARE TRUST reported financial results for the quarter and nine months ended September 30, 2022.
“On November 2, 2022, Diversified Healthcare Trust, or the Company, issued a press release regarding the Company’s results of operations and financial condition for the quarter and nine months ended September 30, 2022”
David A. Pierce was elected as Independent Trustee at DIVERSIFIED HEALTHCARE TRUST.
“our Board elected David A. Pierce as an Independent Trustee of our Board with a term to expire at the Company’s 2023 annual meeting to fill the vacancy created by the increase in size of our Board to seven Trustees.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.